Towards a more competitive Medicare: The case for deregulating medical fees and co-payments in Australia

David GadielMay 3, 2015Research Report 1

GPs have been willing to bulk bill for over 80% of GP consultations, but where local conditions permit, they are comfortable to charge patients what the market will bear. Specialists have generally opposed bulk billing, except (in some instances) for Concession card holders. It is paradoxical that the federal government sets a ‘Schedule Fee’ for Medicare services, when it has no ability to control fees. The reality is that the Medicare Schedule Fee is a misnomer, because it is no more than a ‘benefit’ for medical services. Medicare arrangements should match the constitutional realities. The abolition of the Schedule Fee (by setting it at zero) under the Health Insurance Regulations would enable its replacement by the publication of a ‘benefit payable’ on items listed on the Medicare Benefits Schedule. This would eliminate any need for governments to undertake the politically challenging task of introducing a GP co-payment. The federal government should also save itself the contradiction and the cost of paying GPs incentives to bulk bill by abolishing both the Schedule Fee and the GP incentive payments simultaneously.

 

Related Commentary

Subsidies, safety nets and stagnation: Australia’s new economic model
Michael StutchburyApril 11, 2026AUSTRALIAN FINANCIAL REVIEW
Protecting one industry imposes a burden on the competitive sectors that actually prop up our...
The mental health system may be making us sicker
Steven SchwartzApril 6, 2026CANBERRA TIMES

Australia has a mental health crisis, but not the one we think. Despite decades of...

Housing negative gearing tax
Reducing the discount would likely not have any lasting impact in lowering house prices
Robert Carling, Michael StutchburyMarch 21, 2026CANBERRA TIMES

Anyone watching the smoke signals from Canberra knows that moves are afoot to try and...

• Subscribe

Subscribe now and stay in the loop with our giving appeals, event alerts, newsletters and research updates.

We are always pleased to hear from you. If you have any questions or feedback, please contact us here: